Pharmaceutical Technology
174 articles in the TruthFoundry index. Each links out to the original.
- MarketScan Partner Ecosystem Enhances Real-World Medical Research Data · MarketScan and FinThrive discuss combining claims data with inpatient detail for research.
- FDA issues updated potency assurance guidance for cell and gene therapies · US FDA publishes final guidance requiring stronger potency standards for CGT manufacturing.
- AbbVie discloses $757M migraine drug deal with Brise Pharmaceuticals · AbbVie and Brise Pharmaceuticals publicize a 2024 migraine drug licensing agreement worth up to $757 million.
- Fresenius partners with WuXi Biologics on 37 biosimilar development deal · Fresenius and WuXi Biologics agree to jointly develop up to 37 biosimilar candidates.
- Inovio receives FDA accelerated approval for Voceryq RRP therapy · FDA grants accelerated approval to Inovio's Voceryq for recurrent respiratory papillomatosis
- IDWeek 2026 reports potential ensitrelvir PEP benefit for Covid-19 · IDWeek 2026 findings indicate early ensitrelvir PEP may assist Covid-19 cases.
- Prediction Markets Raise Insider Trading Risks For Private Biotechs · Prediction markets for drug approvals introduce new insider trading risks for biotech firms.
- UK Regulators Expand Casgevy Approval For Patients Aged 5 And Older · MHRA approves Casgevy gene therapy for younger sickle cell and thalassemia patients.
- Glenmark Pharmaceuticals opens dedicated US distribution hub in Allentown · Glenmark Pharmaceuticals inaugurates its sole US distribution hub in Allentown, Pennsylvania.
- RFK Jr enacts policy allowing compounding of six unapproved wellness peptides · US Health Secretary RFK Jr issued policy permitting compounding of six unapproved peptides.
- Enthorin and Rumi sign licensing agreement for Fragile X therapy · Enthorin Therapeutics licenses FXS drug candidate ENT-7340 to Rumi Therapeutics for development.
- Ferring Pharmaceuticals agrees $1.38bn acquisition of startup Gameto · Swiss pharma Ferring will acquire Gameto for up to $1.38bn to expand reproductive health offerings.
- LB6V Lyme disease candidate shows promise despite missed trial endpoint at IDWeek 2026 · LB6V Lyme disease drug demonstrates potential despite failing primary trial endpoint at IDWeek 2026.
- Anthropic plans Nasdaq IPO while expanding internal drug development · AI firm Anthropic files for Nasdaq IPO alongside advancing AI drug discovery programs.
- FDA expands Pfizer Talzenna-Xtandi approval for earlier prostate cancer use · US FDA approved Pfizer's Talzenna-Xtandi for earlier line metastatic prostate cancer treatment
- Regeneron secures $270M US contract extension for Ebola therapy Inmazeb · Regeneron agreed a $270M BARDA contract extension to supply Ebola therapy Inmazeb through 2031.
- China NMPA accepts Innovent sintilimab combination therapy application for melanoma · China's NMPA accepted Innovent's regulatory filing for sintilimab + GC101 for advanced melanoma.
- Bayer Nubeqa Phase III win leaves open clinical questions at ESMO26 · Bayer's Phase III Nubeqa trial success leaves survival and abiraterone questions unresolved.
- GSK's Mo-Rez ADC competes in ovarian cancer field at ESMO26 · Pharmaceutical Technology covers GSK's Mo-Rez ADC at ESMO26 behind a paywall.
- Pharmaceutical Technology offers free premium pharma content access · Pharmaceutical Technology promotes free profile creation for premium industry content
- US restricts Chinese biotech investment, exempts licensing deals · US Treasury adds biotech to outbound investment restrictions under the COINS Act.
- Egypt reforms outdated pharmaceutical pricing framework · Egypt has implemented reforms to its obsolete pharmaceutical pricing system.
- Celltrion Signs $580M Licensing Deal With Kaigene For KG013 Antibody · Celltrion acquires global rights to Kaigene's KG013 antibody via a $580 million licensing agreement.
- CPHI 2026 pharma manufacturing event covers AI adoption · Pharmaceutical Technology gates premium CPHI 2026 content behind free user registration.
- Roche reports 7% pharma sales growth while trimming clinical pipeline · Roche recorded 7% 9M 2026 pharma sales growth while discontinuing nine clinical programs.
- Quality Control Checklist For Sourcing Research-Grade Retatrutide Peptide · This guide outlines verification steps for laboratories procuring retatrutide research material.
- Prediction Markets Raise Insider Trading Risks For Biotech Clinical Sector · Kalshi launched clinical trial betting markets, sparking insider trading concerns for biotechs.
- European Commission approves MSD Keytruda plus Padcev for bladder cancer · EC approves MSD Keytruda-Padcev combination for muscle-invasive bladder cancer treatment
- AbbVie Partners with McLaren F1 Team in 'Race to Innovate' Campaign · AbbVie becomes an official pharmaceutical partner of McLaren F1 team with a multi-year sponsorship deal.
- Pharma Consolidates Logistics Partners to Combat Supplier Sprawl · Pharmaceutical companies are reducing logistics vendors to improve control, costs, and emissions tracking.